German diabetes specialist Emperra has launched the first wireless insulin pen that transfers data to a patient’s blood glucose diary via Bluetooth. The CE-marked device is launching in Germany with an eye toward an FDA approval in 2016.
The pen, called Esysta, gives patients and doctors the ability to map out blood glucose levels and dosing regimens in real time either in person or from remote locations without multiple connections.
The pen can be used by patients with either Type 1 or Type 2 diabetes.
“The smart insulin pen and corresponding software appeal to patients and doctors who prefer state-of-the-art technical solutions and who have recognized that the digitalization of diabetes management is a simple and reliable solution,” Emperra CEO Christian Krey said in a release.
- here's the release